Lili (Aurélie) Nsongo
Stock Analyst at Leerink Partners
(0.12)
# 4,257
Out of 4,339 analysts
38
Total ratings
20%
Success rate
-25.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lili (Aurélie) Nsongo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRD Opus Genetics | Initiated Coverage: Buy | $10 | $4.09 | +144.50% | 1 | May 21, 2026 | |
| VYGR Voyager Therapeutics | Maintained: Buy | $11 | $3.83 | +187.21% | 11 | Dec 15, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Reiterated: Buy | $17 | $7.21 | +135.78% | 18 | Oct 23, 2025 | |
| EPA: ALSEN Sensorion SA | Reiterated: Buy | €3.00 | $0.396 | +657.58% | 8 | Sep 18, 2025 |
Opus Genetics
May 21, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $4.09
Upside: +144.50%
Voyager Therapeutics
Dec 15, 2025
Maintained: Buy
Price Target: $11
Current: $3.83
Upside: +187.21%
Arcturus Therapeutics Holdings
Oct 23, 2025
Reiterated: Buy
Price Target: $17
Current: $7.21
Upside: +135.78%
Sensorion SA
Sep 18, 2025
Reiterated: Buy
Price Target: €3.00
Current: $0.396
Upside: +657.58%